Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sensus Healthcare (SRTS) EBIT (2016 - 2025)

Sensus Healthcare has reported EBIT over the past 10 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put EBIT at $5.1 million for Q4 2025, up 214.97% from a year ago — trailing twelve months through Dec 2025 was -$2.0 million (down 206.6% YoY), and the annual figure for FY2025 was -$2.0 million, down 206.65%.
  • EBIT for Q4 2025 was $5.1 million at Sensus Healthcare, up from -$2.6 million in the prior quarter.
  • Over the last five years, EBIT for SRTS hit a ceiling of $5.6 million in Q4 2023 and a floor of -$4.5 million in Q4 2024.
  • Median EBIT over the past 5 years was $845000.0 (2021), compared with a mean of $922200.0.
  • Biggest five-year swings in EBIT: soared 1969.65% in 2021 and later crashed 271.84% in 2025.
  • Sensus Healthcare's EBIT stood at $5.3 million in 2021, then decreased by 21.56% to $4.2 million in 2022, then surged by 33.68% to $5.6 million in 2023, then tumbled by 180.13% to -$4.5 million in 2024, then surged by 214.97% to $5.1 million in 2025.
  • The last three reported values for EBIT were $5.1 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.9 million (Q2 2025) per Business Quant data.